TREACE MEDICAL CONCEPTS, INC. - TMCI

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G/A Armistice Capital, LLC 9.85% 6,364,000 View
May 15, 2026 SCHEDULE 13G/A Steven Boyd 9.85% 6,364,000 View
May 14, 2026 SCHEDULE 13G BANK OF AMERICA CORP /DE/ 5.5% 3,533,774 View
Feb 17, 2026 SCHEDULE 13G/A Armistice Capital, LLC 9.99% 6,364,000 View
Feb 17, 2026 SCHEDULE 13G/A Steven Boyd 9.99% 6,364,000 View
Feb 12, 2026 SCHEDULE 13G/A Gagnon Securities LLC 6.2% 3,928,051 View
Feb 12, 2026 SCHEDULE 13G/A Gagnon Advisors, LLC 2.4% 1,534,034 View
Feb 12, 2026 SCHEDULE 13G/A Neil Gagnon 9.6% 6,142,107 View
Feb 09, 2026 SCHEDULE 13G/A WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.8% 1,145,498 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.